MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battle
Earlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Diabetes | Empagliflozin | Endocrinology | India Health | Jardiance | Legislation | Pharmaceuticals